Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Asset disposition
Acq. announced
Director departure
Gene Biotherapeutics, Inc. (CRXM) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/03/2014 8-K Asset disposition
Docs: "CARDIUM REPORTS ON ADVANCEMENT OF GENERX AND EXCELLAGEN BIOLOGIC PRODUCTS AND CORPORATE DEVELOPMENTS"
09/27/2012 8-K Form 8-K - Current report
09/04/2012 8-K Asset disposition
Docs: "CARDIUM TO PRESENT AT THE RODMAN & RENSHAW ANNUAL 2012 HEALTHCARE INVESTMENT CONFERENCE"
08/20/2012 8-K Form 8-K - Current report
08/07/2012 8-K Form 8-K - Current report
07/31/2012 8-K Form 8-K - Current report
06/26/2012 8-K Form 8-K - Current report
06/15/2012 8-K Form 8-K - Current report
05/21/2012 8-K Form 8-K - Current report
04/04/2012 8-K Form 8-K - Current report
03/23/2012 8-K Form 8-K - Current report
02/21/2012 8-K Form 8-K - Current report
02/13/2012 8-K Asset disposition
Docs: "Opinion of Sheppard, Mullin, Richter & Hampton LLP",
"Form of Securities Purchase Agreement",
"Placement Agent Agreement between the registration and Ladenburg Thalmann & Co. Inc",
"CARDIUM ANNOUNCES $5.0 MILLION FINANCING WITH INSTITUTIONAL INVESTORS"
02/02/2012 8-K Form 8-K - Current report
01/09/2012 8-K Form 8-K - Current report
01/03/2012 8-K Asset disposition
Docs: "CARDIUM REPORTS ON RENEWED COMPLIANCE WITH NYSE AMEX EXCHANGE LISTING GUIDELINES"
12/14/2011 8-K Form 8-K - Current report
11/16/2011 8-K Form 8-K - Current report
10/11/2011 8-K Form 8-K - Current report
09/29/2011 8-K Form 8-K - Current report
09/01/2011 8-K Form 8-K - Current report
08/30/2011 8-K Form 8-K - Current report
08/24/2011 8-K Form 8-K - Current report
08/05/2011 8-K Asset disposition
Docs: "CARDIUM PROVIDES UPDATE ON EXCELLAGEN"
08/01/2011 8-K Form 8-K - Current report
07/14/2011 8-K Form 8-K - Current report
06/24/2011 8-K Asset disposition
Docs: "CARDIUM ANNOUNCES CEDARS-SINAI HEART INSTITUTE AS THE SPECT IMAGING CORE LAB FOR THE RECENTLY ANNOUNCED GENERX ® PHASE 3 CLINICAL REGISTRATION STUDY IN THE RUSSIAN FEDERATION"
06/17/2011 8-K Asset disposition
Docs: "GENERX DNA-BASED ANGIOGENIC THERAPY RECEIVES RUSSIAN MINISTRY OF HEALTH CLEARANCE FOR LATE-STAGE REGISTRATION CLINICAL STUDY FOR CORONARY ARTERY DISEASE"
06/14/2011 8-K Asset disposition
Docs: "TO SUPPORT COGNITIVE PERFORMANCE EXPANDING THE MEDPODIUM HEALTHY LIFESTYLE PRODUCT LINE"
03/31/2011 8-K Form 8-K - Current report
03/09/2011 8-K Form 8-K - Current report
01/26/2011 8-K Form 8-K - Current report
01/20/2011 8-K Form 8-K - Current report
01/10/2011 8-K Form 8-K - Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy